» Articles » PMID: 25945240

Investigation on Metabolism of Cisplatin Resistant Ovarian Cancer Using a Genome Scale Metabolic Model and Microarray Data

Overview
Specialty General Medicine
Date 2015 May 7
PMID 25945240
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Many cancer cells show significant resistance to drugs that kill drug sensitive cancer cells and non-tumor cells and such resistance might be a consequence of the difference in metabolism. Therefore, studying the metabolism of drug resistant cancer cells and comparison with drug sensitive and normal cell lines is the objective of this research.

Material And Methods: Metabolism of cisplatin resistant and sensitive A2780 epithelial ovarian cancer cells and normal ovarian epithelium has been studied using a generic human genome-scale metabolic model and transcription data.

Result: The results demonstrate that the most different metabolisms belong to resistant and normal models, and the different reactions are involved in various metabolic pathways. However, large portion of distinct reactions are related to extracellular transport for three cell lines. Capability of metabolic models to secrete lactate was investigated to find the origin of Warburg effect. Computational results introduced SLC25A10 gene, which encodes mitochondrial dicarboxylate transporter involved in exchanging of small metabolites across the mitochondrial membrane that may play key role in high growing capacity of sensitive and resistant cancer cells. The metabolic models were also used to find single and combinatorial targets that reduce the cancer cells growth. Effect of proposed target genes on growth and oxidative phosphorylation of normal cells were determined to estimate drug side-effects.

Conclusion: The deletion results showed that although the cisplatin did not cause resistant cancer cells death, but it shifts the cancer cells to a more vulnerable metabolism.

Citing Articles

Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer.

Meeson K, Schwartz J NPJ Syst Biol Appl. 2024; 10(1):96.

PMID: 39181893 PMC: 11344801. DOI: 10.1038/s41540-024-00418-5.


Targeting metabolic fluxes reverts metastatic transitions in ovarian cancer.

Arora G, Banerjee M, Langthasa J, Bhat R, Chatterjee S iScience. 2023; 26(11):108081.

PMID: 37876796 PMC: 10590820. DOI: 10.1016/j.isci.2023.108081.


The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer.

Zhou B, Mai Z, Ye Y, Song Y, Zhang M, Yang X Hum Cell. 2022; 35(6):1900-1911.

PMID: 36104652 DOI: 10.1007/s13577-022-00775-5.


MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44.

Liu X, Zhao T, Yuan Z, Ge S Cell Death Discov. 2022; 8(1):216.

PMID: 35443748 PMC: 9021257. DOI: 10.1038/s41420-022-01000-w.


Reconstruction of a generic genome-scale metabolic network for chicken: Investigating network connectivity and finding potential biomarkers.

Salehabadi E, Motamedian E, Shojaosadati S PLoS One. 2022; 17(3):e0254270.

PMID: 35316277 PMC: 8939822. DOI: 10.1371/journal.pone.0254270.


References
1.
Jones N, Schulze A . Targeting cancer metabolism--aiming at a tumour's sweet-spot. Drug Discov Today. 2011; 17(5-6):232-41. DOI: 10.1016/j.drudis.2011.12.017. View

2.
Echtay K, Roussel D, St-Pierre J, Jekabsons M, Cadenas S, Stuart J . Superoxide activates mitochondrial uncoupling proteins. Nature. 2002; 415(6867):96-9. DOI: 10.1038/415096a. View

3.
Mirandola S, Melo D, Schuck P, Ferreira G, Wajner M, Castilho R . Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis. 2008; 31(1):44-54. DOI: 10.1007/s10545-007-0798-1. View

4.
Toyoshima S, Watanabe F, Saido H, Miyatake K, Nakano Y . Methylmalonic acid inhibits respiration in rat liver mitochondria. J Nutr. 1995; 125(11):2846-50. DOI: 10.1093/jn/125.11.2846. View

5.
Li M, Balch C, Montgomery J, Jeong M, Chung J, Yan P . Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics. 2009; 2:34. PMC: 2712480. DOI: 10.1186/1755-8794-2-34. View